Over 30 Top Silicon Valley, New York City, and Los Angeles venture capital investors are joining Notable Labs to help raise funding and awareness for the Leukemia & Lymphoma Society (LLS) through the 2018 VC Master Lunch Auction Series. The 2018 auction features opportunities to meet one-on-one and receive critical advice from partners at 8VC, a16z, Builders VC, Data Collective VC, DFJ, Eclipse Ventures, Eleven Two, First Round Capital, Founders Fund, Fuel Capital, GV (Google Ventures), Homebrew, Initialized Capital, Lerer Hippeau, New Enterprise Associates (NEA), NextView Ventures, Obvious Ventures, Pioneer Fund, Red Swan Ventures, Refactor, Sequoia, Susa Ventures, SV Angel, Trinity Ventures, Upfront, and Y Combinator. The 2018 VC Master Lunch Auction Series honors Rhett Krawitt, a 10-year old boy who was diagnosed with B-Cell Acute Lymphoblastic Leukemia in 2010. Five years ago, then 5-year-old Rhett rallied venture capitalists for the 2013 auction with the slogan “My name is Rhett and I give a damn!”
Learn more about the participating venture capitalists, bidding, and how LLS helped Rhett to be #GoneWithTheCancer here: https://bit.ly/2wOfctF
LLS is the world’s largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services. Research funding by LLS has led or contributed to such advances as chemotherapy, bone marrow and stem cell transplantation and new, targeted oral therapies such as Gleevec, Rituxin, Velcade and Vidaza.